Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Intraoperative Goal-directed Blood Pressure Management and Dexmedetomidine on Outcomes of High-risk Patients After Major Abdominal Surgeries: a 2×2 Factorial Randomized Controlled Trial

NCT03933306 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT03933306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03933306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Intraoperative Goal-directed Blood Pressure Management and Dexmedetomidine on Outcomes of High-risk Patients After Major Abdominal Surgeries: a 2×2 Factorial Randomized Controlled Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 20, 2019
Completion date
May 30, 2024
Enrollment
496 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal surgery, blood pressure, dexmedetomidine, high-risk patients, postoperative complications